Casdin Capital as of June 30, 2017
Portfolio Holdings for Casdin Capital
Casdin Capital holds 34 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 10.7 | $29M | 360k | 80.19 | |
| Sage Therapeutics (SAGE) | 7.5 | $20M | 255k | 79.64 | |
| Foundation Medicine | 7.1 | $19M | 480k | 39.75 | |
| Blueprint Medicines (BPMC) | 5.2 | $14M | 275k | 50.67 | |
| Evolent Health (EVH) | 4.9 | $13M | 520k | 25.35 | |
| Agios Pharmaceuticals (AGIO) | 4.8 | $13M | 255k | 51.45 | |
| Sangamo Biosciences (SGMO) | 4.6 | $12M | 1.4M | 8.80 | |
| Clovis Oncology | 4.5 | $12M | 130k | 93.63 | |
| SPDR S&P Biotech (XBI) | 4.3 | $12M | 150k | 77.18 | |
| Spark Therapeutics | 3.8 | $10M | 170k | 59.74 | |
| Gilead Sciences (GILD) | 3.5 | $9.6M | 135k | 70.79 | |
| Kite Pharma | 3.5 | $9.3M | 90k | 103.67 | |
| Alnylam Pharmaceuticals (ALNY) | 3.1 | $8.4M | 105k | 79.76 | |
| GenMark Diagnostics | 3.0 | $8.1M | 685k | 11.83 | |
| Epizyme | 2.9 | $7.9M | 520k | 15.10 | |
| Audentes Therapeutics | 2.8 | $7.7M | 400k | 19.13 | |
| Bluebird Bio (BLUE) | 2.5 | $6.8M | 65k | 105.05 | |
| Tesaro | 2.5 | $6.7M | 48k | 139.85 | |
| Voyager Therapeutics (VYGR) | 2.5 | $6.6M | 740k | 8.96 | |
| Codexis (CDXS) | 2.4 | $6.5M | 1.2M | 5.45 | |
| Global Blood Therapeutics In | 2.2 | $5.9M | 215k | 27.35 | |
| Illumina (ILMN) | 2.0 | $5.5M | 32k | 173.52 | |
| Myokardia | 1.9 | $5.2M | 395k | 13.10 | |
| Syros Pharmaceuticals | 1.1 | $2.9M | 182k | 16.09 | |
| Cytomx Therapeutics (CTMX) | 1.0 | $2.8M | 178k | 15.50 | |
| Myriad Genetics (MYGN) | 1.0 | $2.6M | 100k | 25.84 | |
| Ovid Therapeutics (OVID) | 0.9 | $2.3M | 222k | 10.49 | |
| Editas Medicine (EDIT) | 0.8 | $2.2M | 133k | 16.78 | |
| Jounce Therapeutics | 0.8 | $2.2M | 160k | 14.03 | |
| Allscripts Healthcare Solutions (MDRX) | 0.7 | $1.9M | 150k | 12.76 | |
| Fate Therapeutics (FATE) | 0.7 | $1.8M | 550k | 3.24 | |
| Amyris | 0.6 | $1.6M | 500k | 3.18 | |
| Pacific Biosciences of California (PACB) | 0.4 | $1.1M | 300k | 3.56 | |
| Curis | 0.1 | $161k | 85k | 1.89 |
